Rare diseases
Investigational molecules
Locations
Recruiting trials first
28 clinical trials in this condition
Austria
Poland
BelgiumAustriaIn short
When you find yourself short of breath or develop a persistent dry cough, getting the right diagnosis becomes the first step toward understanding what's happening in your lungs and finding the best way forward.
Knowing when to seek medical attention for potential interstitial lung disease is crucial for early detection and better management of the condition. If you experience shortness of breath that seems out of proportion to your usual level of fitness, especially if it gets worse with physical activity or exertion, this is an important signal that should not be ignored. Many people mistakenly believe that becoming breathless is simply part of getting older, but this assumption can delay important diagnosis. While it's true that aerobic capacity naturally declines with age, suddenly finding yourself out of breath from activities like walking up stairs or doing household chores deserves medical evaluation.
A persistent dry cough is another key symptom that warrants diagnostic testing. This type of cough doesn't produce mucus and can be bothersome, often lasting for months. When a dry cough appears alongside increasing breathlessness, the combination becomes even more significant. You might also notice other symptoms like unusual fatigue that doesn't improve with rest, chest discomfort, or unexplained weight loss. These symptoms typically start mild but gradually worsen over months or years, which is why early medical attention matters.
Certain groups of people should be particularly alert to these symptoms and seek diagnostics promptly. If you are over 70 years old, male, or have a history of smoking, you face higher risk for developing interstitial lung disease. People who work or have worked in environments where they were exposed to substances like asbestos, silica, molds, fungi, or bacteria should also be vigilant. Additionally, if you have been diagnosed with conditions such as rheumatoid arthritis, lupus, scleroderma, hepatitis C, tuberculosis, or chronic obstructive pulmonary disease (COPD), you may be at increased risk. Those who have undergone chest radiation for cancer treatment should also monitor their breathing closely.
Diagnosing interstitial lung disease can be challenging because there are over 200 different conditions that fall under this umbrella term, and symptoms can appear similar to many other medical conditions. Healthcare providers must carefully rule out other possibilities before confirming a diagnosis. The diagnostic process typically begins with something seemingly simple but actually quite valuable: a thorough conversation about your health history and a physical examination.
During your initial visit, your doctor will spend considerable time asking detailed questions about your symptoms, when they started, and how they have progressed. This conversation will also cover your complete work history, looking for any potential exposure to harmful substances. Your doctor will ask about medications you take, any radiation treatment you've received, and whether you have autoimmune conditions or other health problems. This extensive medical history is often the first and most important step in identifying the cause of lung problems. The physical examination that follows will include listening to your lungs with a stethoscope, checking for clubbing (rounding) of your fingers and toes, and looking for other physical signs of lung disease.
Blood tests play an important role in the diagnostic process. These tests can detect specific proteins, antibodies, and other markers in your blood that might indicate autoimmune diseases such as rheumatoid arthritis, lupus, or scleroderma, all of which can cause interstitial lung disease. Blood work can also reveal inflammatory responses to environmental exposures, such as reactions to molds or proteins from birds. Additional laboratory tests check for signs of inflammation throughout your body by measuring liver function, inflammatory markers, hemoglobin levels, and electrolytes. Some blood tests can even detect evidence of muscle inflammation that might be related to your lung condition.
Imaging tests are essential for visualizing what is happening inside your lungs. The most important imaging test for diagnosing interstitial lung disease is a computed tomography scan, also called a CT scan. This test is often the key to diagnosis and may even be the first test ordered. CT scanners use X-rays to produce detailed three-dimensional images of your internal structures. A high-resolution CT scan is especially helpful because it can show the extent of lung damage with remarkable detail. It can reveal patterns of scarring (called fibrosis) that help doctors narrow down the specific type of interstitial lung disease you might have and guide decisions about treatment.
A chest X-ray is a simpler imaging test that may be performed first, though it provides less detail than a CT scan. While a chest X-ray can show abnormalities in the lungs, it often cannot provide enough information to make a definitive diagnosis of interstitial lung disease. An echocardiogram uses sound waves to create moving pictures of your heart. This test is important because interstitial lung disease can affect the heart, particularly the right side, due to increased pressure in the lung's blood vessels. The echocardiogram can measure this pressure and help doctors understand how your heart is coping with your lung condition.
Pulmonary function tests measure how well your lungs are working. The most common test is called spirometry, which requires you to breathe out quickly and forcefully through a tube connected to a machine. The machine measures how much air your lungs can hold and how quickly you can move air out of your lungs. This test can also measure your lung volumes and something called diffusion capacity, which measures how well oxygen crosses from the air sacs in your lungs into your bloodstream. In interstitial lung disease, this measurement is often reduced because the scarring makes it harder for oxygen to pass through the damaged tissue. Another common test is the six-minute walk test, where you walk for six minutes while your oxygen levels are monitored. This helps doctors understand how your lungs perform during physical activity.
An arterial blood gas test measures the acidity of your blood and the amounts of oxygen and carbon dioxide it contains. This test involves taking a small sample of blood from an artery, usually in your wrist. It provides direct information about how well your lungs are transferring oxygen into your bloodstream and removing carbon dioxide. An oxygen saturation test is a simpler, non-invasive test that uses a small device clipped onto your finger to measure the oxygen level in your blood. This can be done while you're at rest and during exercise to see how your oxygen levels change with activity.
Sometimes, despite thorough testing, doctors need to examine actual lung tissue to make a definitive diagnosis. A bronchoscopy is a procedure where a thin, flexible tube with a camera on the end is passed through your nose or mouth into your airways. During this procedure, doctors can see inside your lungs and take small tissue samples (biopsies) for examination under a microscope. They can also perform a bronchoalveolar lavage, where a small amount of sterile salt water is squirted into a section of the lung and then collected. The fluid is analyzed for cells and other substances that might help identify the cause of your lung disease.
In some cases, a surgical lung biopsy may be necessary. This can be done through a procedure called video-assisted thoracic surgery, which uses small incisions and a camera to guide the surgeon in taking tissue samples from different areas of the lung. Although this is more invasive than bronchoscopy, it often provides larger and more useful tissue samples that can lead to a more accurate diagnosis. The tissue samples are then examined by a specialist called a pathologist who looks for specific patterns of damage and scarring that characterize different types of interstitial lung disease.
Your doctor may order other specialized tests depending on what they suspect is causing your lung problems. If there's concern about an autoimmune condition, you might have antibody testing to check for specific markers of diseases like rheumatoid arthritis or scleroderma. If occupational exposure is suspected, detailed questions about your work environment and the substances you've been exposed to become particularly important. Sometimes genetic testing may be recommended, especially if there's a family history of lung disease or if you have childhood interstitial lung disease, which can have genetic causes.
When patients with interstitial lung disease consider participating in clinical trials, they must undergo specific diagnostic tests to determine if they meet the study's eligibility criteria. Clinical trials are research studies that test new treatments or approaches to managing disease, and they have strict requirements about who can participate. These requirements exist to ensure the safety of participants and the scientific validity of the study results. The diagnostic tests used for clinical trial qualification are often similar to those used for standard diagnosis, but they may be more extensive or require more precise measurements.
Pulmonary function testing is almost always required for clinical trial enrollment in interstitial lung disease studies. Trials typically specify minimum and maximum values for lung function measurements such as forced vital capacity (the total amount of air you can forcefully exhale after taking the deepest breath possible) and diffusion capacity. These measurements help ensure that participants have a level of disease severity that matches what the trial is designed to study. For example, some trials may focus on early-stage disease and therefore only accept patients whose lung function hasn't declined too much, while others might specifically study more advanced disease.
High-resolution CT scans are critical for clinical trial qualification because they provide detailed information about the patterns and extent of lung damage. Trial researchers need to confirm that participants have the specific type of interstitial lung disease being studied. The CT images are often reviewed by specialized radiologists who look for characteristic patterns of scarring and can measure how much of the lung is affected. Some trials may require that CT scans be performed within a certain timeframe before enrollment to ensure the information is current.
Blood tests for clinical trials may go beyond routine diagnostic work. Researchers might require specific antibody tests to rule out certain autoimmune diseases or to confirm the absence of particular conditions. Some trials measure inflammatory markers in the blood to track disease activity. Genetic testing might be required for trials studying inherited forms of interstitial lung disease or for trials of treatments that work differently depending on a person's genetic makeup. Blood samples may also be collected for research purposes to better understand the disease and how different patients respond to treatment.
The six-minute walk test is frequently used in clinical trials as both an enrollment criterion and a way to measure how well treatment is working. This simple test measures how far you can walk in six minutes while your oxygen levels are monitored. It provides information about your exercise capacity and how well your body handles physical activity despite your lung disease. Clinical trials often require that you can walk a minimum distance to participate, ensuring that participants are healthy enough for the study while still having enough disease burden to potentially benefit from the experimental treatment.
Documentation of disease progression may be required for some clinical trials. This means you might need to show through previous test results that your lung function has declined over a specific period, perhaps six months or a year. This requirement helps trials select patients whose disease is active and progressing, who might benefit most from new treatments. Researchers might compare your current pulmonary function tests with tests from several months earlier to calculate the rate at which your lung function is declining.
A comprehensive review of your medical history is essential for trial qualification. You'll need to provide detailed information about all your current health conditions, every medication you take (including over-the-counter drugs and supplements), previous treatments you've received, and any other lung diseases or significant health problems you've had. Clinical trials often exclude people with certain other medical conditions or those taking specific medications that might interfere with the study treatment or make participation unsafe. You may need to have your medical records sent from previous healthcare providers to document your history of interstitial lung disease diagnosis and treatment.
Quality of life questionnaires are sometimes part of the screening process for clinical trials. These standardized forms ask detailed questions about how your lung disease affects your daily activities, your ability to work, your emotional well-being, and your overall quality of life. The information helps researchers understand the full impact of the disease and provides baseline measurements that can be tracked during the trial to see if new treatments improve not just lung function but also how people feel and function in their daily lives.
The outlook for people with interstitial lung disease varies considerably depending on the specific type of ILD, how early it is diagnosed, and how well it responds to treatment. Because there are over 200 different conditions classified as interstitial lung disease, the prognosis can range from mild and stable to serious and progressive. Most forms of ILD cause irreversible lung damage, meaning that scarring that has already occurred cannot be undone. However, this doesn't mean the outlook is hopeless. The most serious forms are progressive, where the condition continues to worsen over time, but the rate of progression can vary significantly from person to person and some types may remain stable for extended periods.
Several factors influence how the disease will progress. Age plays a role, with people over 70 facing higher risk of more serious disease. Smoking history significantly affects prognosis, as smoking can make lung damage worse. The underlying cause of the ILD matters greatly—for example, ILD caused by exposure to harmful substances may stabilize if the exposure is eliminated, while idiopathic forms (where the cause is unknown) may be more unpredictable. Early diagnosis and appropriate treatment can help prevent further scarring and slow disease progression, which is why recognizing symptoms and seeking medical care promptly is so important.
The historical view that interstitial lung disease meant patients had only three to five years to live is now outdated for all but one form of the disease. This prognosis applied primarily to idiopathic pulmonary fibrosis (IPF), the most severe type. However, even for IPF, earlier diagnosis combined with newly available FDA-approved medications and promising experimental therapies in clinical trials have changed the outlook. Many forms of ILD can be managed effectively, and with proper treatment and lifestyle changes, many patients can maintain a good quality of life for years after diagnosis.
Survival rates for interstitial lung disease depend heavily on the specific type of ILD diagnosed. For the most severe form, idiopathic pulmonary fibrosis, the average survival time has historically been between three and five years from diagnosis. However, this statistic is changing as new treatments become available and diagnosis occurs earlier in the disease process. It's important to understand that these are average figures, and many individuals live significantly longer, especially when they receive early diagnosis and appropriate treatment.
For other forms of interstitial lung disease, survival rates can be much better. Some types of ILD may remain stable for many years or even decades, particularly when the underlying cause can be identified and addressed. For example, when ILD is caused by medication and that medication is stopped, or when it's caused by occupational exposure and the person is no longer exposed to the harmful substance, the disease progression may halt or slow dramatically. People with ILD associated with autoimmune conditions may have survival rates that reflect both their lung disease and their underlying autoimmune condition.
A significant concern for survival is the development of complications. Without proper treatment, ILD can lead to life-threatening problems including frequent lung infections, respiratory failure (when the body doesn't get enough oxygen or accumulates too much carbon dioxide), high blood pressure in the lungs (pulmonary hypertension), and right-sided heart failure. These complications can substantially affect survival. However, following a treatment plan carefully, avoiding substances that worsen lung damage, getting recommended vaccines, managing other health conditions, and seeking prompt medical care for any worsening of symptoms can help prevent these complications and improve outcomes.
About 30 to 40 percent of people with interstitial lung disease eventually develop pulmonary fibrosis, which has a median survival of 2.5 to 3.5 years. This statistic emphasizes why early intervention and ongoing medical care are crucial. For some patients whose disease progresses despite treatment, lung transplantation may be an option, which can significantly extend survival and improve quality of life. The key message is that while ILD is a serious condition, it is no longer considered simply a death sentence, and many factors influence how long people can live with appropriate medical care.
This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
